期刊文献+

肥胖型和非肥胖型多囊卵巢综合征患者的内分泌特征比较 被引量:5

Comparison of endocrine characteristics between obese and non-obese women with polycystic ovary syndrome
下载PDF
导出
摘要 目的探讨肥胖型和非肥胖型多囊卵巢综合征(PCOS)患者的内分泌特征是否相同。方法选择就诊的未经过药物治疗的PCOS患者211例,分为肥胖组和非肥胖组,分别检测其基础血清总睾酮(TT)、硫酸脱氢表雄酮(DHEAS)、性激素结合球蛋白(SHBG)、卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)、孕酮(PO)及催乳素(PRL)水平,并对其进行统计分析。结果肥胖组PCOS患者的SHBG、LH、E2和PO明显低于非肥胖组,差异有统计学意义(P<0.05)。PCOS患者肥胖与TT、FSH及E2绝对正相关,与SHBG、LH及PO绝对负相关,差异有统计学意义(P<0.05)。结论肥胖型和非肥胖型PCOS患者的基础内分泌指标间存在差异,这对于进一步了解PCOS的发病机制及异质性具有重要意义。 Objective To investigate whether having the same endocrine characteristics in non-obese and obese women with polycystic ovary syndrome(PCOS).Methods 211 untreated women with PCOS were selected and divided into the obese group and the non-obese group.The basal levels of serum total testosterone(TT),dehydroepiandrosterone sulfate(DHEAS),sex hormone binding globulin(SHBG),follicle stimulating hormone(FSH),luteinizing hormone(LH),estradiol(E2),progesterone(PO)and prolactin(PRL)were measured and the results were analyzed statistically.Results The basal SHBG,LH,E2 and PO levels in the PCOS patients of the obese group were significantly lower than those of the non-obese group,the difference was statistically significant(P〈0.05).Obese was absolutely positively correlated with the TT,FSH and E2 levels in the PCOS patients,but absolutely inversely correlated with the SHBG,LH and PO levels(P〈0.05).Conclusion The difference of basal endocrine indicators exist between non-obese and obese women with PCOS,which has an important significance for further understanding the pathogenesis and heterogeneity of PCOS.
出处 《检验医学与临床》 CAS 2015年第21期3172-3174,共3页 Laboratory Medicine and Clinic
基金 首都医科大学附属北京妇产医院院内课题(2013-13)
关键词 多囊卵巢综合征 肥胖 内分泌指标 异质性 PCOS obese endocrine indicators heterogeneity
  • 相关文献

参考文献20

  • 1Dumitrescu R,Mehedintu C,Briceag I,et al. The Polycys- tic Ovary Syndrome.. An update on metabolic and hormo- nal mechanisms[J]. J Med Life,2015,8(2) :142-145.
  • 2Trikudanathan S. Polycystic ovarian syndrome[J].Med Clin North Am,2015,99(1) :221-235.
  • 3Goodarzi MO,Dumesic DA, Chazenbalk G, et al. Polycys- tic ovary syndrome: etiology, pathogenesis and diagnosis [J]. Nat Rev Endocrinol,2011,7(4) :219-231.
  • 4Lungu AO, Zadeh ES, Goodling A, et al. Insulin resistance is a sufficient basis for hyperandrogenism in lipodystr0- phic women with polycystic ovariansyndrome[J].J Clin Endocrinol Metab, 2012,97 (2) : 563-567.
  • 5谷郁婷.PCOS合并胰岛素抵抗与血脂代谢异常的相关性分析[J].当代医药论丛,2014,12(21):53-54. 被引量:3
  • 6EckIund LC, Usadi RS. Endocrine and reproductive effects of polycystic ovarian syndrome[J]. Obstet Gynecol Clin North Am,2015,42(1) :55-65.
  • 7Gambineri A,Pelusi C,Vicennati V,et al. Obesity and the polycystic ovary syndrome[J]. Int J Obes Relat MetabDisord, 2002,26(7):883-896.
  • 8Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients[J]. J Clin Endocrinol Metab, 2004,89 (2) : 453- 462.
  • 9The Rotterdam ESHRE/ASRM sponsored PCOS work shop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].Hum Reprod, 2004,19 ( 1 ) : 41-47.
  • 10多囊卵巢综合征的诊断和治疗专家共识[J].中华妇产科杂志,2008,43(7):553-555. 被引量:320

二级参考文献37

共引文献327

同被引文献28

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部